Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …

17. When managing NSGCTs, PM is indicated for select patients with limited number of lung
abnormalities after first-line or second-line platin-based chemotherapy suspected of …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …

Background and purpose To evaluate whether local tumor control probability (TCP) in
stereotactic body radiotherapy (SBRT) varies between lung metastases of different primary …

Introduction Stereotactic body radiation therapy (SBRT) is applied in the oligometastatic
setting to treat liver metastases. However, factors influencing tumor control probability (TCP) …

Background We evaluated a series of oligometastatic colorectal cancer (CRC) patients
treated with stereotactic ablative body radiotherapy (SABR) delivered in all active lung …

Background SBRT is a novel modality in treatment for oligometastatic colorectal cancer. We
aimed to perform a systematic review of results of SBRT in maintaining LC (local control) for …

Colorectal cancer (CRC) is one of the most common causes of death from cancer. Lung
seeding occurs in approximately 10% of patients surgically treated for primary CRC with …

Purpose: The purpose of this study was to determine whether pulmonary oligometastases
from colorectal cancer have greater radioresistance than that of pulmonary oligometastases …

Purpose Stereotactic ablative radiation therapy (SABR) is increasingly used to treat lung
oligometastases. We set out to determine the safety and efficacy of this approach and to …